Fibrinogen as a Key Binding Partner in Human Plasma for Lecanemab Biosimilar IgG
Jean‐Pierre Bellier, Andrea M Román Viera, Caitlyn Christiano, Juliana A U Anzai, Stephanie Moreno, Emily C Campbell, Lucas Godwin, Amy Li, Alan Y Chen, Sarah Alam, Adrianna Saba, Han bin Yoo, Hyun‐Sik Yang, Jasmeer P Chhatwal, Dennis J Selkoe, Lei Liu · 2025
Read Fibrinogen as a Key Binding Partner in Human Plasma for Lecanemab Biosimilar IgG by Jean‐Pierre Bellier, Andrea M Román Viera, Caitlyn Christiano, Juliana A U Anzai, Stephanie Moreno, Emily C Campbell, Lucas Godwin, Amy Li, Alan Y Chen, Sarah Alam, Adrianna Saba, Han bin Yoo, Hyun‐Sik Yang, Jasmeer P Chhatwal, Dennis J Selkoe, Lei Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712674.txt.
Description
A mind ill drug that hunts the brain's plaque is shot in the vein each two weeks, and what it rides in the blood can shift its stay. Jean-Pierre Bellier and co-authors hunt its rides in a 2025 study with a twin of the drug, built from its free code. Blood cuts were split and probed for bound shares.
One ride stood out: the clot stock that seals cuts. Pull and glow tests back the pair, and a wave read weighs their grip. The grip is weak next to the drug's plaque grip, by a wide span. Still, the team say, clot stock may act as a tank that holds free drug low. Blood rides, they urge, belong in drug plans for brain ills.
Catalog record
| CREATOR | Jean‐Pierre Bellier, Andrea M Román Viera, Caitlyn Christiano, Juliana A U Anzai, Stephanie Moreno, Emily C Campbell, Lucas Godwin, Amy Li, Alan Y Chen, Sarah Alam, Adrianna Saba, Han bin Yoo, Hyun‐Sik Yang, Jasmeer P Chhatwal, Dennis J Selkoe, Lei Liu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |